Mouse monoclonal antibody for creatine kinase-MB detection. Validated on chemiluminescence, immunochromatography, and immunoturbidimetry platforms. Available as product K68t3 and K69v5 with batch-to-batch stability for in vitro diagnostic applications.
Manufactured by
Nanjing Okay Biotechnology Co., Ltd.
China
Nanjing Okay Biotechnology Co., Ltd. is a high-tech enterprise specializing in R&D, production, and sales of in-vitro diagnostic (IVD) raw materials. The company provides antigens, antibodies, enzymes, and core reagents for immunochromatography, immunoturbidimetry, chemiluminescence, and microfluidic IVD applications. Supported by high-throughput flow cytometry screening, comprehensive testing, and large-scale production platforms.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
HeavyBio, Inc
China · 6 relevant products
SDIX, LLC
United States · 8 relevant products
JTC Diagnosemittel GmbH
Germany · 2 relevant products
54 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 93 closest product alternatives
HeavyBio, Inc · China
Mouse antibody for creatine kinase isoenzyme MB capture in CLIA platforms. Used to detect myocardial injury markers, CK-MB is one of the most widely used clinical markers today for diagnosing myocardial infarction and evaluating patient prognosis.
HeavyBio, Inc · China
Mouse antibody for creatine kinase isoenzyme MB detection used in CLIA platforms. CK-MB is a cardiac marker that increases 4-6 hours after myocardial injury, peaks at 24 hours, and returns to normal within 3 days, serving as a widely used clinical marker of myocardial damage.
SDIX, LLC · United States
A monoclonal antibody targeting human CKMB (creatine kinase-MB). This product is designed for cardiac diagnostic applications and myocardial infarction detection.
90 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products